Based on the information available, the recommended wait time for live vaccines after taking Cosentyx (secukinumab) is not explicitly stated in the drug's prescribing information or clinical trial data. However, it is generally recommended to avoid live vaccines during immunosuppressive therapy due to the potential risk of vaccine-induced infection [1].

Cosentyx, a medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, is an interleukin-17A inhibitor that can affect the immune system [1]. Therefore, it is crucial to consult with a healthcare provider before receiving any vaccinations while on Cosentyx or other immunosuppressive therapies [1].

Sources:
[1] Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. Accessed: March 29, 2023. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
[2] DrugPatentWatch.com. Secukinumab. Accessed: March 29, 2023. <https://www.drugpatentwatch.com/drugs/secukinumab>